Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals

Biotechnology Research

Lexington, Massachusetts 21,203 followers

Relentless. Passionate. Focused

About us

Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. At Kiniksa, patients are at the heart of everything we do. Our Every Second Counts! mindset reflects our commitment to making a difference for people who are navigating the uncertainty and challenges of life-altering diseases. This is why our team is relentless in pursuing treatments that bring us closer to a better future for patients, every second of every day. We rely on an exceptional team to drive our mission of building a global, generational company. If you're passionate about making a meaningful impact, we’d love to hear from you. Kiniksa offers competitive benefits and dynamic career opportunities across our organization. We foster a culture of passion, innovation, and rapid execution to help fulfill our mission.

Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
Lexington, Massachusetts
Type
Public Company
Founded
2015

Locations

Employees at Kiniksa Pharmaceuticals

Updates

Similar pages

Browse jobs

Funding

Kiniksa Pharmaceuticals 4 total rounds

Last Round

Post IPO equity

US$ 80.0M

See more info on crunchbase